Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
11.79
-0.37 (-3.04%)
At close: Jun 27, 2025, 4:00 PM
11.70
-0.09 (-0.76%)
After-hours: Jun 27, 2025, 6:06 PM EDT
Adaptive Biotechnologies Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Adaptive Biotechnologies stock ranges from a low of $6.00 to a high of $15. The average analyst price target of $10.57 forecasts a -10.35% decrease in the stock price over the next year.
Price Target: $10.57 (-10.35%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Adaptive Biotechnologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 3 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +27.23% | Jun 18, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +10.26% | May 6, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $9 | Hold | Maintains | $7 → $9 | -23.66% | May 5, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | -15.18% | May 2, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $8 → $9 | Hold → Strong Buy | Upgrades | $8 → $9 | -23.66% | Mar 21, 2025 |
Financial Forecast
Revenue This Year
222.73M
from 178.96M
Increased by 24.46%
Revenue Next Year
267.83M
from 222.73M
Increased by 20.25%
EPS This Year
-0.87
from -1.08
EPS Next Year
-0.66
from -0.87
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 234.3M | 293.2M | 369.2M | |
| Avg | 222.7M | 267.8M | 336.7M | |
| Low | 209.4M | 238.6M | 304.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 30.9% | 31.6% | 37.8% | |
| Avg | 24.5% | 20.2% | 25.7% | |
| Low | 17.0% | 7.1% | 13.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.85 | -0.49 | -0.22 |
| Avg | -0.87 | -0.66 | -0.37 |
| Low | -0.89 | -0.86 | -0.46 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.